Acute Myeloid Leukemia
Author and Disclosure Information [Show]

Pankit Vachhani, MD

Clinical Fellow, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Elizabeth A. Griffiths, MD

Associate Professor of Oncology, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Read the full article Acute Myeloid Leukemia.

Question 1 of 5

A 79-year-old woman with a history of hypertension, heart failure with ejection fraction of 45%, and rheumatoid arthritis managed with methotrexate is diagnosed with adverse-risk cytogenetics acute myeloid leukemia (AML). Laboratory findings are notable for a white blood cell (WBC) count of 2000/µL with 25% blasts, hemoglobin 8.0 g/dL, platelet count 76 × 103/µL, serum creatinine 0.8 mg/dL, alanine aminotransferase (ALT) 20 U/L, and aspartate aminotransferase (AST) 22 IU/L. Despite some fatigue and dyspnea on exertion, she is ambulatory and able to take care of her household chores.

What is the most reasonable next management course to recommend?

Intensive chemotherapy with anthracycline and cytarabine

Intensive chemotherapy with CPX-351 (liposomal 5:1 molar concentration of cytarabine and daunorubicin)

Hypomethylating agent

Basic supportive care (predominantly transfusions)

Hospice referral

Hospital Physician: Hematology/Oncology. 2018 August;13(4)

This quiz is not accredited for CME.

More from Board Review Questions: Hematology/Oncology


Autoimmune Hemolytic Anemia
Gastrointestinal Stromal Tumors
Testicular Cancer
Management of Advanced Melanoma
Castration-Resistant Prostate Cancer
Transfusion Reactions (part 2)
Transfusion Reactions (part 1)
Plasma Cell Disorders (part 3)
Plasma Cell Disorders (part 2)
Chronic Myeloid Leukemia
Aplastic Anemia
Small Cell Lung Cancer
Management of Metastatic Gastric Cancer
Transfusion Medicine
Management of Colorectal Cancer in Older Adults
Urothelial Carcinoma: Muscle-Invasive and Metastatic Disease
Pancreatic Adenocarcinoma: Advanced Unresectable and Metastatic Disease
HER2-Positive Breast Cancer
Aggressive B-Cell Non-Hodgkin Lymphoma
Von Willebrand Disease: Assessment and Diagnostic Testing
Von Willebrand Disease: Clinical Management
Pancreatic Adenocarcinoma: Neoadjuvant and Adjuvant Treatment
Late Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Polycythemia Vera and Essential Thrombocythemia: Current Management
Treatment of Biliary Tract Cancers
Early Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Hairy Cell Leukemia
Genomic Testing in Women with Early-Stage Hormone Receptor–Positive, HER2-Negative Breast Cancer
Immune Thrombocytopenia
Cancer-Related Fatigue
Disseminated Intravascular Coagulation
Advanced Stage and Relapsed/Refractory Hodgkin Lymphoma
Adjuvant Chemotherapy for Colon Cancer
Molecular Markers and Targeted Therapies in the Management of Non-Small Cell Lung Cancer
Metastatic Cutaneous Melanoma: Targeted Therapy and Immunotherapy
Thrombosis in Pregnancy
Locally Advanced Pancreatic Cancer
Early-Stage Hodgkin Lymphoma
Neoadjuvant and Adjuvant Therapy for Gastric Cancer
Hemophilia A and B
Mantle Cell Lymphoma
Soft Tissue Sarcoma
Sickle Cell Disease
Renal Cell Carcinoma
Management of Locally Advanced Rectal Adenocarcinoma
Adjuvant Systemic Therapy for Early-Stage Breast Cancer
Chronic Myeloid Leukemia
Plasma Cell Disorders
Myelodysplastic Syndromes
Acute and Chronic Graft-versus-Host Disease